U.S Physical Therapy Cost of Goods Sold 2010-2024 | USPH

U.S Physical Therapy cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
U.S Physical Therapy Annual Cost of Goods Sold
(Millions of US $)
2023 $483
2022 $441
2021 $378
2020 $329
2019 $369
2018 $352
2017 $323
2016 $275
2015 $253
2014 $229
2013 $199
2012 $187
2011 $176
2010 $155
2009 $150
U.S Physical Therapy Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $139
2024-06-30 $133
2024-03-31 $127
2023-12-31 $124
2023-09-30 $122
2023-06-30 $119
2023-03-31 $118
2022-12-31 $113
2022-09-30 $113
2022-06-30 $110
2022-03-31 $105
2021-12-31 $103
2021-09-30 $96
2021-06-30 $93
2021-03-31 $86
2020-12-31 $88
2020-09-30 $79
2020-06-30 $65
2020-03-31 $97
2019-12-31 $95
2019-09-30 $90
2019-06-30 $95
2019-03-31 $90
2018-12-31 $92
2018-09-30 $87
2018-06-30 $88
2018-03-31 $85
2017-12-31 $85
2017-09-30 $82
2017-06-30 $80
2017-03-31 $77
2016-12-31 $72
2016-09-30 $69
2016-06-30 $67
2016-03-31 $66
2015-12-31 $65
2015-09-30 $65
2015-06-30 $62
2015-03-31 $60
2014-12-31 $60
2014-09-30 $59
2014-06-30 $56
2014-03-31 $53
2013-12-31 $52
2013-09-30 $50
2013-06-30 $49
2013-03-31 $48
2012-12-31 $47
2012-09-30 $47
2012-06-30 $47
2012-03-31 $46
2011-12-31 $45
2011-09-30 $46
2011-06-30 $43
2011-03-31 $42
2010-12-31 $40
2010-09-30 $39
2010-06-30 $39
2010-03-31 $38
2009-12-31 $38
2009-09-30 $38
2009-06-30 $37
2009-03-31 $36
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.380B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00